Citation Impact
Citing Papers
Vaginal microbiome of reproductive-age women
2010 Standout
Poverty Impedes Cognitive Function
2013 StandoutScience
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
Accelerated telomere shortening in response to life stress
2004 StandoutNobel
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
1998
Cancer and depression.
1996
Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma
2001
Depression After Diagnosis of Advanced Non-Small Cell Lung Cancer and Survival: A Pilot Study
2008
Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients
1986 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Increasing incidence of cancers associated with the human immunodeficiency virus epidemic
1991
CD34+ Cord Blood Cell-Transplanted Rag2−/− γc−/− Mice as a Model for Epstein-Barr Virus Infection
2008
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Global Cancer Statistics, 2002
2005 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Natural History of Primary Epstein‐Barr Virus Infection in Children of Mothers Infected with Human Immunodeficiency Virus Type 1
1999
Impact of Anemia and Cardiovascular Disease on Frailty Status of Community-Dwelling Older Women: The Women's Health and Aging Studies I and II
2005
Aids-related malignancies
2002
Epidemiology of HPV infection among Mexican women with normal cervical cytology
2001
Pharmacoeconomic considerations in the management of acute tumor lysis syndrome
2001
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
2003
Novel applications of liposomes
1998
Non-compliance—or how many aunts has Matilda?
1993 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer
2001
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Heat Stroke
2002 Standout
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Liposomal daunorubicin in advanced Kaposi's sarcoma: A phase II study
1993
Pharmacokinetics of Pegylated Liposomal Doxorubicin
2003
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.
1997
Effects of Bacterial Vaginosis and Other Genital Infections on the Natural History of Human Papillomavirus Infection in HIV‐1–Infected and High‐Risk HIV‐1–Uninfected Women
2005
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus–Like Particles in Human Immunodeficiency Virus (HIV)–Positive and High‐Risk HIV–Negative Women
2003
The benefits of being present: Mindfulness and its role in psychological well-being.
2003 Standout
Protective and Damaging Effects of Stress Mediators
1998 Standout
Host factors in the pathogenesis of HIV disease
1997
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Patient Adherence and Medical Treatment Outcomes
2002 Standout
Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource Settings
2001
Engineering liposomes for drug delivery: progress and problems
1995
Recent developments in the field of antitumour anthracyclines
2001
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer
2002
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
HIV as the cause of AIDS
1996 StandoutNobel
Major Depressive Disorder
2008 Standout
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
1995 Standout
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
2001
Case-Control Study of Non-Hodgkin's Lymphoma among Women and Heterosexual Men in the San Francisco Bay Area, California
1999
Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes
1997
Serum Immunoglobulin G Response to Human Papillomavirus Type 16 Virus‐Like Particles in Human Immunodeficiency Virus (HIV)–Positive and Risk‐Matched HIV‐Negative Women
2003
The CD4 lymphocyte count and risk of clinical progression
2006
Malignant Melanoma
1993
Infección por los virus del papiloma humano y de la inmunodeficiencia humana como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas
2000
The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker
1998
Advanced and controlled drug delivery systems in clinical disease management
1996
Kaposi's Sarcoma
2000 Standout
Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma
2000
Frailty in elderly people
2013 Standout
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
External Genital Warts: Diagnosis, Treatment, and Prevention
2002
Adherence to Therapy With Oral Antineoplastic Agents
2002
Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma
2002
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Epstein–Barr Virus Infection
2000 Standout
Adherence to Medication
2005 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Epidemiology of lymphomas
2000
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
A Critical Evaluation of the Methodology of the Literature on Medication Compliance
1999
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Paclitaxel Is Safe and Effective in the Treatment of Advanced AIDS-Related Kaposi's Sarcoma
1999
Oncogenic Human Papillomavirus DNA Loads in Human Immunodeficiency Virus-Positive Women with High-Grade Cervical Lesions Are Strongly Elevated
2003
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Exercise and the Immune System: Regulation, Integration, and Adaptation
2000
Acquired immunodeficiency syndrome-related lymphoma [see comments]
1992
Nucleotide sequence of Mason-Pfizer monkey virus: An immunosuppressive D-type retrovirus
1986
Polymeric Systems for Controlled Drug Release
1999 Standout
Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I–II study
2002
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Conjugated Polymer-Based Chemical Sensors
2000 Standout
Polymersomes: Tough Vesicles Made from Diblock Copolymers
1999 StandoutScience
Nucleotide Sequence of SRV-1, a Type D Simian Acquired Immune Deficiency Syndrome Retrovirus
1986 Science
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.
1999
Cancer and Depression
1996
Acquired immunodeficiency syndrome-related lymphoma [see comments]
1992
Detection and Possible Prognostic Relevance ofp53Gene Mutations in Diffuse Large B-cell Lymphoma. An Analysis of 51 Cases and Review of the Literature
2004
Response to Liposomal Doxorubicin and Clinical Outcome of HIV-1–Infected Patients with Kaposi’s Sarcoma Receiving Highly Active Antiretroviral Therapy
2001
Spermidine in health and disease
2018 StandoutScience
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Pathogenesis of human immunodeficiency virus infection
1993
Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma
2004
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
State-of-the-Art Therapeutics: Hodgkin's Lymphoma
2005
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
1999
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Works of A Levine being referenced
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
1995
Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies
2004
Cervicovaginal Human Papillomavirus Infection in Human Immunodeficiency Virus-1 (HIV)-Positive and High-Risk HIV-Negative Women
1999
Chemotherapy Consisting of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine With Granulocyte–Colony-Stimulating Factor in HIV-Infected Patients With Newly Diagnosed Hodgkin's Disease: A Prospective, Multi-institutional AIDS Clinical Trials Group Study (ACTG 149)
2000
The effect of compliance with treatment on survival among patients with hematologic malignancies.
1990
Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive Women
2003
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin’s lymphoma
2001
IL-10 Inhibits HIV-1 Replication and Is Induced by Tat
1994
Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine
1990
AIDS-related lymphoma
1999
Lymphoma complicating immunodeficiency disorders
1994
AIDS-Related Malignancies: the Emerging Epidemic
1993
Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial.
1997
Hematologic Aspects of HIV/AIDS
2001
The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy.
1988
Highly Active Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-Positive Women
2004
Compliance with oral drug therapy in patients with hematologic malignancy.
1987
Retrovirus and malignant lymphoma in homosexual men
1985
Molecular comparison of retroviruses associated with human and simian AIDS
1985
Non-Hodgkin's lymphomas in never married men in Los Angeles
1985
B cell acute lymphocytic leukemia in adults. Clinical, morphologic, and immunologic findings.
1986
AIDS-related malignant lymphoma: results of prospective treatment trials.
1987